Telehealth & Digital Health

Pharma veteran Pinder Sahota joins digital health firm Reset Health, signaling a strategic shift to integrated care in the new era of weight-loss drugs.

Zelluna partners with Medpace for a first-in-human trial of its ZIMA-101 TCR-NK therapy, a new 'off-the-shelf' approach for hard-to-treat solid tumors.

A new book offers a critical roadmap for medical device developers facing a storm of new AI regulations, complex FDA rules, and evolving IP law.

Bolstered by a top regulatory expert and unique veterinary data, Vivos Inc. is set to file for human trials of its precision injectable cancer treatment.

A new webinar explores how integrating data into EHRs is overcoming major barriers to improve mental health outcomes. Learn how this tech revolutionizes care.

With a fresh $118M in funding, Garner Health's AI platform aims to cut healthcare costs by guiding millions of patients to top-rated doctors.

Enanta Pharmaceuticals unveils promising data for EDP-978, an oral drug targeting the root cause of conditions like chronic hives, asthma, and eczema.

A national report card gives the U.S. a 'B' on rare disease policy, but stark state-by-state disparities leave millions vulnerable to financial ruin.

A new company aims to solve why patients stop neurological treatments, focusing on the critical, unsupported time between doctor appointments.

A new long-acting CBD injection shows major promise for arthritic dogs, and the company is now in talks with the FDA for human applications.

Backed by a proven billion-dollar impact model, 14 new startups are using AI, neuroscience, and philanthropy to revolutionize mental healthcare.

With its lead drug in Phase 3, Celldex will update investors at three major conferences, highlighting its immunology pipeline and financial strategy.

A new alliance between Tend Health and SafeHavenMD offers a confidential lifeline to doctors battling burnout, integrating peer support with clinical care.

With a promising spinal cord injury drug nearing late-stage trials, NervGen appoints interim leader Dr. Adam Rogers as permanent CEO to guide the breakthrough.

Heart disease is the leading cause of premature death for Canadian women, yet it remains under-diagnosed and under-treated. A national movement is fighting back.

A 15-year pharma alliance expands to Austria, bringing advanced relief to cancer patients suffering from chemotherapy's debilitating side effects.

Zoya Technologies unveils an autonomous AI clinic that operates without the cloud, promising to revolutionize healthcare in underserved regions worldwide.

A national scholarship founded by a top neurosurgeon invests in students poised to solve healthcare’s biggest challenges, addressing critical workforce shortages.

Airrosti launches REACH, a new platform combining its proven myofascial release model with digital tools to tackle the $350B MSK problem.

After winning a major award, OnMed's tech-enabled CareStation promises to revolutionize access to care. But can this hybrid model solve a national crisis?